Sintx Technologies, Inc. SINT
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -55.96%
- 1 year
- -49.85%
- Open
- 1.70
- Prev close
- 1.71
- Mkt cap
- 12.85M
- Vol
- 4.67K
- Avg vol
- 115.78K
- EPS
- -4.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.68
- High
- 1.72
- Forward P/E
- -0.32
- Beta
- 1.37
- Short ratio
- 0.71
- Inst. own
- 1.71%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.35
- 200-d avg
- 6.58
- 1y target
- 0.00
News
1 week ago globenewswire.com
SINTX Technologies Announces Third Quarter 2026 Earnings Release Date and Webcast
SALT LAKE CITY, Utah, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced silicon nitride biomaterials and ceramics for medical…
3 weeks ago zacks.com
What Makes SINTX TECHNOLOGIES (SINT) a New Buy Stock
SINTX TECHNOLOGIES (SINT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
1 month ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Anbio Biotechnology (NASDAQ:NNNN) stock moved upwards by 16.9% to $6.49 during Friday's after-market session. The market value of their outstanding shares is at $276.0 million. Stablecoin…
-
1 month ago benzinga.com
SINTX Reports Preliminary Q3 Revenue of $2.2M, Exceeding High End Of Company’s Previously Announced Guidance Of $0.9M-$1.1M
Third-quarter revenue grows roughly 380% from Q2, driven by stronger-than-expected industrial sales to Fortune 500 customers; Company reiterates Q4 revenue guidance Revenue milestone also enables…
1 month ago globenewswire.com
SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance
Third-quarter revenue grows roughly 380% from Q2, driven by stronger-than-expected industrial sales to Fortune 500 customers; Company reiterates Q4 revenue guidance Revenue milestone also enables…
-
1 month ago benzinga.com
Ascendiant Capital Maintains Buy on SINTX Technologies, Raises Price Target to $12.5
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and raises the price target from $12 to $12.5.
1 month ago defenseworld.net
Avanos Medical (NYSE:AVNS) and Sintx Technologies (NASDAQ:SINT) Financial Analysis
Sintx Technologies (NASDAQ: SINT - Get Free Report) and Avanos Medical (NYSE: AVNS - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two…
1 month ago defenseworld.net
Reviewing Cooper Companies (NASDAQ:COO) and Sintx Technologies (NASDAQ:SINT)
Sintx Technologies (NASDAQ: SINT - Get Free Report) and Cooper Companies (NASDAQ: COO - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two…
1 month ago globenewswire.com
SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts
Experts in implant retrieval, biomaterials and clinical practice examine the science, clinical experience and potential advantages of silicon nitride relative to established implant materials in…
1 month ago globenewswire.com
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
SALT LAKE CITY, Utah, Sept. 08, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company commercializing proprietary…
2 months ago zacks.com
SINTX TECHNOLOGIES (SINT) Moves to Buy: Rationale Behind the Upgrade
SINTX TECHNOLOGIES (SINT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
-
2 months ago benzinga.com
SINTX Technologies Regains Nasdaq Compliance
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a company focused on advanced silicon nitride materials and medical technologies, today announced that it received written…
2 months ago globenewswire.com
SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement
SALT LAKE CITY, Utah, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a company focused on advanced silicon nitride materials and medical…
2 months ago seekingalpha.com
Sintx Technologies, Inc. (SINT) Q2 2026 Earnings Call Prepared Remarks Transcript
Sintx Technologies, Inc. (SINT) Q2 2026 Earnings Call Prepared Remarks Transcript
-
2 months ago benzinga.com
SINTX Technologies Q2 EPS $(0.75) Misses $(0.66) Estimate, Sales $452.000K Beat $406.667K Estimate
SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.66) by 13.64 percent. This is a 17.58 percent increase over losses…
2 months ago globenewswire.com
SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives
SALT LAKE CITY, Utah, Aug. 11, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced silicon nitride biomaterials and ceramics for medical…
3 months ago globenewswire.com
SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and Webcast
SALT LAKE CITY, Utah, July 28, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced silicon nitride ceramics and advanced material…
3 months ago globenewswire.com
SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program
SALT LAKE CITY, Utah, July 23, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced biomaterials and silicon nitride technologies for…
-
4 months ago benzinga.com
SINTX Technologies Receives Purchase Orders From Multiple Contract Manufacturing Customers With Aggregate Value Exceeding $3.2M For Production Of Advanced Ceramic Components
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride ceramics and advanced material technologies, today announced that it has received purchase…
4 months ago globenewswire.com
SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders
SALT LAKE CITY, Utah, June 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced silicon nitride ceramics and advanced material…
-
5 months ago benzinga.com
Maxim Group Reinstates Buy on SINTX Technologies, Announces $6 Price Target
Maxim Group analyst Anthony Vendetti reinstates SINTX Technologies (NASDAQ:SINT) with a Buy and announces $6 price target.
5 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
-
5 months ago benzinga.com
SINTX Technologies Announces $4.5M Private Placement, Issuing 1,882,845 Shares At $2.39 Combined Price With Warrants For 1,882,845 Class A And 1,882,845 Class B Shares Exercisable At $2.14
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced biomaterials company focused on developing silicon nitride technologies for medical applications, today announced that…
5 months ago globenewswire.com
SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
SALT LAKE CITY, Utah, June 03, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced biomaterials company focused on developing silicon nitride…
5 months ago benzinga.com
Why SINTX Technologies Stock Is Trading Lower Today
Shares of SINTX Technologies are trading lower Wednesday afternoon following the company's disclosure of a Nasdaq non-compliance notice.
-
5 months ago benzinga.com
Sintx Technologies Receives Nasdaq Noncompliance Notice, Gets Time Through July 6 To Regain Compliance
https://www.sec.gov/ix?doc=/Archives/edgar/data/1269026/000149315226025377/form8-k.htm
-
5 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on SINTX Technologies, Maintains $10 Price Target
HC Wainwright & Co. analyst Brandon Folkes reiterates SINTX Technologies (NASDAQ:SINT) with a Buy and maintains $10 price target.
5 months ago newsfilecorp.com
SINTX Technologies to Present at the LD Micro Invitational XVI Conference
Salt Lake City, Utah--(Newsfile Corp. - May 17, 2026) - SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a medical technology company focused on advanced ceramics and silicon…
-
5 months ago benzinga.com
SINTX Technologies Q1 EPS $(0.70) Misses $(0.66) Estimate, Sales $380.000K Beat $300.000K Estimate
SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.66) by 6.06 percent. This is a 45.74 percent increase over losses of…
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
6 months ago defenseworld.net
Sintx Technologies (NASDAQ:SINT) versus Vasamed (OTCMKTS:VSMD) Critical Review
Sintx Technologies (NASDAQ: SINT - Get Free Report) and Vasamed (OTCMKTS:VSMD - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies…
-
6 months ago benzinga.com
HC Wainwright & Co. Initiates Coverage On SINTX Technologies with Buy Rating, Announces Price Target of $10
HC Wainwright & Co. analyst Brandon Folkes initiates coverage on SINTX Technologies (NASDAQ:SINT) with a Buy rating and announces Price Target of $10.
-
6 months ago benzinga.com
Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $12
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and lowers the price target from $16 to $12.
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
7 months ago benzinga.com
SINTX Releases Corporate Update On Key Milestones, Including First Human Surgical Procedure Using FDA-Approved Foot & Ankle Osteotomy Wedge System
Recent 2026 Milestones and Execution Progress::Completed first human implant of the SINAPTIC Foot & Ankle Osteotomy Wedge SystemAppointed Ryan Elmore as President to lead commercialization and…
7 months ago globenewswire.com
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution
Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026
-
7 months ago benzinga.com
SINTX Technologies Completes First-In-Human Surgical Procedure Utilizing FDA-Cleared SINAPTIC Foot & Ankle Osteotomy Wedge System
Major clinical milestone marks SINTX's entry into the foot and ankle reconstruction market and advances commercialization of its silicon nitride biomaterial platformSALT LAKE CITY, Utah, March 19,…
7 months ago globenewswire.com
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant
Major clinical milestone marks SINTX's entry into the foot and ankle reconstruction market and advances commercialization of its silicon nitride biomaterial platform
8 months ago defenseworld.net
Critical Analysis: OPKO Health (NASDAQ:OPK) vs. Sintx Technologies (NASDAQ:SINT)
OPKO Health (NASDAQ: OPK - Get Free Report) and Sintx Technologies (NASDAQ: SINT - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two…
-
10 months ago benzinga.com
Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $16
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and lowers the price target from $25 to $16.
-
11 months ago benzinga.com
SINTX Technologies Strikes Supply Agreement With Evonik To Produce Proprietary Silicon Nitride-PEEK Compound
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company, today announced that it has signed a supply agreement with Evonik Corporation…
-
11 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
11 months ago benzinga.com
SINTX Technologies Q3 EPS $(1.19) Misses $(0.51) Estimate, Sales $208.000K Miss $300.000K Estimate
SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate of $(0.51) by 133.33 percent. This is a 82.9 percent increase over losses…
-
11 months ago benzinga.com
SINTX Technologies Receives FDA 510(K) Clearance For Its SINAPTIC Foot & Ankle Osteotomy Wedge System
SALT LAKE CITY, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company focused on…
-
11 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
1 year ago benzinga.com
SINTX Technologies Announces FDA 510(K) Clearance For SINAPTIC Foot & Ankle Osteotomy Wedge System; SINTX Plans U.S. Commercial Launch In Q1 2026
FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT)…
-
1 year ago benzinga.com
SINTX Technologies Secures Patent for Antipathogenic Fabric Methods, Strengthening Infection-Resistant IP
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced that the United…
-
1 year ago benzinga.com
SINTX Technologies Expands Patent Protections for Antipathogenic Fabrics, Strengthening Biomedical IP Portfolio
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced that the United…
-
1 year ago benzinga.com
Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $25
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and lowers the price target from $28 to $25.
-
1 year ago benzinga.com
SINTX Raises $3.8M Through Warrant Exercise to Strengthen Working Capital
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced the entry into…